# Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine

> **NCT01876966** · PHASE1 · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 33 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Etravirine
- **DRUG:** Darunavir/ritonavir
- **DRUG:** artemether/lumefantrine

## Key facts

- **NCT ID:** NCT01876966
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2013-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01876966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01876966, "Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01876966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*